Considering the inhibitory effect of cancer cells on the function of effector lymphocytes in TIME via immunological checkpoints, such as PD-L1, it is more comprehensive and precise to stratify TIME into different types by combining the two indicators above. This evidence concerns the gene CD274 and cancer.